These findings highlight the importance of optimizing escalation protocols in future studies
Semaglutide, the active ingredient in Wegovy and Ozempic, slows digestion , meaning food stays in your stomach longer
This study investigated the potential association between GLP-1RAs and SSIBs by exploring the FDA Adverse Event Reporting System (FAERS) database
82,83 In addition to lowering blood sugar levels, liraglutide helps to reduce body weight by suppressing appetite and reducing energy intake, 84,85 but its associated costs and need for daily injections may limit its use in individuals with obesity
Major adverse cardiovascular events (MACE) The research examined eight large cohorts of T2DM patients, with cardiovascular outcome trials (CVOTs), for main MACE outcomes, including cardiovascular death, nonfatal MI, and nonfatal stroke, which were studied with GLP1RAs [40]
BMC Nutr